←
Shreeram Akilesh 🐙544 posts
Shreeram Akilesh 🐙 avatar

Shreeram Akilesh 🐙

@podocytes

Associate Professor, Renal Pathologist and #kidneyomics Researcher. Tweets are my opinions not medical advice. #renalpath

◷ Joined August 2012▧ 139 Photos and videos
Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

Just in time for #WorldKidneyDay, I'm happy to share our latest work on human kidney endothelial cells published today in BJC Reports. We use single-cell RNA-seq, tissue & cell-based validation studies to study the unique phenotypes of these cells. (1/14) nature.com/articles/s44276-0…

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·18 Oct 2024

At @ASNKidney #KidneyWk 2024 next week in San Diego, I will discuss the potential of clinical translation of spatial transcriptomics technologies. Saturday, Oct. 26 at noon, Room 6A, including some unpublished preprint data: biorxiv.org/content/10.1101/…

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Oct 2024

Also, while there is a kidney focus in this review, the concepts and principles are generally applicable. So please share with your non-kidney friends! 😉

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Oct 2024

This was an awesome collab with @oligopain! Thanks to @NatRevNeph editors and staff for guiding us through this huge undertaking. We couldn't cover everything, but we hope this is a useful primer for studying the 3D and 4D genome in the kidney: rdcu.be/dW2aM

Tobias B. Huber avatar
⟳ Shreeram Akilesh 🐙 retweeted
Tobias B. Huber@Tobias_B_Huber·19 Jun 2024

The inherent complexity of the kidney makes it an ideal validation platform for showcasing topographical molecular mapping: Multiscale topology classifies cells in subcellular spatial transcriptomics | Nature nature.com/articles/s41586-0…

Faisal Mahmood avatar
⟳ Shreeram Akilesh 🐙 retweeted
Faisal Mahmood@AI4Pathology·12 Jun 2024

⚡️🔬📣 Excited to share our new @Nature article building and evaluating PathChat, a multimodal generative AI copilot and chatbot for human pathology. Article: nature.com/articles/s41586-0… Open Access Link: rdcu.be/dKC0r We leverage our previous success in building foundation models for computational pathology such as UNI / CONCH and combine it with the advancements of large vision language models and generative AI to enable PathChat to answer diverse pathology-related queries. We assessed PathChat using both multiple choice diagnostic questions and open-ended questions. Congratulations to @MYLu97 @chenbowen118 @DFKW_MD @richardjchen and everyone else who contributed to this work. Also see blog post from @MYLu97 about this work: linkedin.com/pulse/towards-m… , also teasing the development and preview of PathChat 2, a successor to PathChat 1 bringing new capabilities and substantially improved performance to the state-of-the-art.

1:30
Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·12 Apr 2024

Spatial transcriptomics technologies have great potential for clinical translation. In this commentary, @kelsmith_path, myself and colleagues discuss practical considerations, costs, and challenges in moving these technologies to the clinic: karger.com/gdz/article/4/1/4…

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

This work was supported by a DOD Kidney Cancer Research Program TRPA, an NCI pilot award and the Cancer Therapeutics Endowment. Shared Resources of the Fred Hutch/UW Cancer Consortium (P30 CA015704) and the HPC team at Fred Hutch funded by ORIP grant S10OD028685. (14/14) 🙏

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

Did you catch that? Tumor endothelial cells have distinct immune cell binding preferences. T-regs and monocytes are more likely to bind to them. So, even before cell-based immunotherapies can interact with the tumor, they have to interact with the tumor endothelium... (12/14)

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

Finally, we studied the functional properties of kidney tumor endos in culture. We asked if various immune cells (isolated from the same patient's tumor, normal adjacent tissue (NAT) or PBMC) could preferentially adhere to their tumor or normal endos (11/14)

Post attachment
Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

We next asked if we could study primary tumor and normal endos in culture. While they became 'simpler', cultured endothelial cells maintained a large fraction of their expression programs stably in culture even without tumor cells, immune cells or the microenvironment! (10/14)

Post attachment
Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

Let that sink in... This means that normal endothelial cells are diverse and fulfill unique functions in their host organ. By contrast, tumor endothelial cells from liver and kidney cancers (and maybe other tumors) have a convergent/shared phenotype!! 🤯 (9/14)

Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

Comparing to liver cancer, we found that while the normal endos from kidney and liver were distinct and varied, 92.4% of RCC tumor endos overlapped with liver cancer endothelial cells. Here's a combined UMAP of both datasets. Most tumor cells overlap shared clusters (8/14)

Post attachment
Shreeram Akilesh 🐙 avatar
Shreeram Akilesh 🐙@podocytes·15 Mar 2024

Our study is the *deepest* dataset of primary ccRCC tumor endothelial cells (the normal endothelial dataset is pretty deep too). Next we decided to see if tumor endothelial cells from different tumors shared similar gene expression programs... (7/14)